- Meeting abstract
- Open Access
Combined 1H MRI, PET and Multinuclear MRS hybrid imaging system
© Hankiewicz et al; licensee Springer 2014
- Published: 29 July 2014
- Positron Emission Tomography
- Magnetic Resonance Spectroscopy
- Molecular Imaging
- Hybrid Imaging
- Soft Tissue Contrast
In this abstract we describe a novel method of combining three imaging modalities: 1H Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and multinuclear Magnetic Resonance Spectroscopy (MRS) in one system dedicated for true molecular imaging.
The addition of PET to MRI was introduced to provide functional/metabolic information about diseases or natural processes in the human body. High resolution and soft tissue contrast of 1H MRI morphological images is complemented by PET’s ability to depict metabolic processes through the use of biologically active radioactively labeled imaging agents, paving the way for molecular imaging.
The application of localized 1H MRS is implemented by using the imaging coil tuned to proton resonances. Localized, or MRI-guided, MR spectroscopy enables quantification of chemical composition of different tissue components in small volumes of less than 0.1 ml. Particularly in the brain, 1H MRS can for example measure accurately N-acetyl aspartate (NAA), lactate, glutamate, creatine, and choline to provide a view of the progression of neuro-degeneration.
However, the use of coil exclusively tuned to 1H significantly limits the “window” of observation by elimination of other biologically relevant nuclei like 13C, 14N, 17O, or 31P. Therefore we propose introducing a second resonator that will be tuned to these nuclei. We anticipate that MRS of other than 1H nuclei will provide more spectroscopic details and remove the ambiguity that exists in the 1H spectra from overlapping lines. The additional coil tuned to specific X-nuclei can be embedded within the existing 1H coil or can be removable, to be added whenever MRS on these nuclei is deemed necessary.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.